When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to see how it compared to a one-time antibody injection ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

Don’t let winter ailments slow you down. Discover how understanding your symptoms can lead to powerful relief while embracing ...

RSV can cause severe infection of the lungs in infants and older adults, according to Mayo Clinic. Researchers say this antibody helps reduce lower respiratory infections that need medical attention.

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

The CDC's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for respiratory syncytial virus.

The U.S. Food and Drug Administration has approved Merck's Enflonsia, a treatment to prevent respiratory syncytial virus lower respiratory tract disease in newborns and infants. The company said ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.